Clarivate Plc (FRA:16A)
2.720
+0.020 (0.74%)
At close: Jan 6, 2026
Clarivate Revenue
Clarivate had revenue of $623.10M USD in the quarter ending September 30, 2025, with 0.31% growth. This brings the company's revenue in the last twelve months to $2.56B, down -2.38% year-over-year. In the year 2024, Clarivate had annual revenue of $2.56B, down -2.74%.
Revenue (ttm)
$2.56B
Revenue Growth
-2.38%
P/S Ratio
0.92
Revenue / Employee
$213.22K
Employees
12,000
Market Cap
1.96B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.56B | -72.10M | -2.74% |
| Dec 31, 2023 | 2.63B | -31.00M | -1.17% |
| Dec 31, 2022 | 2.66B | 782.90M | 41.71% |
| Dec 31, 2021 | 1.88B | 902.56M | 92.63% |
| Dec 31, 2019 | 974.35M | 5.88M | 0.61% |
| Dec 31, 2018 | 968.47M | 50.83M | 5.54% |
| Dec 31, 2017 | 917.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Clarivate News
- 3 days ago - Goldman Sachs Downgrades Clarivate (CLVT) with Lower Price Target | CLVT Stock News - GuruFocus
- 5 days ago - Wall Street Breakfast Podcast: DHS Calls Out Hilton Over ICE - Seeking Alpha
- 5 days ago - Clarivate (CLVT) Highlights Key Therapies in 2026 Drugs to Watch Report - GuruFocus
- 5 days ago - Clarivate Plc: Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report - Finanz Nachrichten
- 5 days ago - Clarivate unveils 2026 Drugs to Watch highlighting 11 promising therapies - Seeking Alpha
- 5 days ago - Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report - PRNewsWire
- 24 days ago - Clarivate Plc: Nissan Selects IPfolio from Clarivate - Finanz Nachrichten
- 24 days ago - Nissan Selects IPfolio from Clarivate - PRNewsWire